Company Filing History:
Years Active: 2009
Title: Maud Deruaz: Innovator in CC-Chemokine Binding Proteins
Introduction
Maud Deruaz is a prominent inventor based in Carouge, Switzerland. She has made significant contributions to the field of immunology through her innovative research and development of novel compounds. Her work focuses on the isolation and application of CC-chemokine binding proteins, which have important implications for treating various diseases.
Latest Patents
Maud Deruaz holds a patent for "CC-chemokine binding tick proteins." This patent describes a novel CC-chemokine binding protein isolated from saliva. The compounds prepared in accordance with this invention can be utilized as anti-inflammatory and immunomodulatory agents. They are particularly relevant in the treatment or prevention of CC-chemokine-related diseases. She has 1 patent to her name.
Career Highlights
Maud Deruaz is currently employed at Merck Serono S.A., a leading biopharmaceutical company. Her role involves extensive research and development in the field of immunology. She has been recognized for her innovative approaches and contributions to the scientific community.
Collaborations
Maud has collaborated with notable colleagues, including Amanda Proudfoot and Christine Power. These collaborations have further enhanced her research and the impact of her inventions in the field.
Conclusion
Maud Deruaz is a trailblazer in the development of CC-chemokine binding proteins, with a focus on their therapeutic applications. Her work at Merck Serono S.A. and her innovative patent highlight her significant contributions to science and medicine.